Recent research in the field of nonviral gene delivery vectors has focused on preparing nanoparticles that are stabilized by the incorporation of a PEG coating and where one of the vector components is also cleavable. Here,we describe the synthesis, formulation, transfection properties, and biophysical studies of a PEG-stabilized ternary lipopolyplex vector in which, for the first time, both the lipid and peptide components are designed to be cleaved once the vector has been internalized. A series of cationic lipids, bearing short tri- or hexaethylene glycol groups, attached to the headgroup via an ester linkage, has been prepared. Trifunctional peptides have also been prepared, consisting of a Lys(16) sequence at the N-terminus (to bind an...
Non–viral gene vectors exhibit several desirable properties, over their viral counterparts. This has...
AbstractTrapping in the endosomes is currently believed to represent the main barrier for transfecti...
AbstractCationic lipid-DNA (CL-DNA) complexes are abundantly used in nonviral gene therapy clinical ...
The structure, biophysical properties and biological behavior of lipopolyplex ternary gene delivery ...
1 - ArticleNonviral gene delivery vectors now show good therapeutic potential: however, detailed cha...
Objectives To date a large number of vesicle-forming cationic lipids and peptides have been synthesi...
A major obstacle in the development of gene therapy is delivery of therapeutic genes to the desired ...
International audienceThe approval of two mRNA vaccines as urgent prophylactic treatments against Co...
The insertion of biocompatible amino acid moieties in non-viral gene nanocarriers is an attractive a...
The main objective of gene therapy via a systemic pathway is the development of a stable and non-tox...
Successful non-viral gene therapy is driven by the molecular makeup and architecture of the gene vec...
International audienceSystemic gene delivery systems are needed for therapeutic application to organ...
International audienceSystemic gene delivery systems are needed for therapeutic application to organ...
Receptor targeted, PEGylated transfection agents can improve stability and delivery specificity of c...
The use of cationic liposomes to deliver nucleic acids has shown great promise; however, their thera...
Non–viral gene vectors exhibit several desirable properties, over their viral counterparts. This has...
AbstractTrapping in the endosomes is currently believed to represent the main barrier for transfecti...
AbstractCationic lipid-DNA (CL-DNA) complexes are abundantly used in nonviral gene therapy clinical ...
The structure, biophysical properties and biological behavior of lipopolyplex ternary gene delivery ...
1 - ArticleNonviral gene delivery vectors now show good therapeutic potential: however, detailed cha...
Objectives To date a large number of vesicle-forming cationic lipids and peptides have been synthesi...
A major obstacle in the development of gene therapy is delivery of therapeutic genes to the desired ...
International audienceThe approval of two mRNA vaccines as urgent prophylactic treatments against Co...
The insertion of biocompatible amino acid moieties in non-viral gene nanocarriers is an attractive a...
The main objective of gene therapy via a systemic pathway is the development of a stable and non-tox...
Successful non-viral gene therapy is driven by the molecular makeup and architecture of the gene vec...
International audienceSystemic gene delivery systems are needed for therapeutic application to organ...
International audienceSystemic gene delivery systems are needed for therapeutic application to organ...
Receptor targeted, PEGylated transfection agents can improve stability and delivery specificity of c...
The use of cationic liposomes to deliver nucleic acids has shown great promise; however, their thera...
Non–viral gene vectors exhibit several desirable properties, over their viral counterparts. This has...
AbstractTrapping in the endosomes is currently believed to represent the main barrier for transfecti...
AbstractCationic lipid-DNA (CL-DNA) complexes are abundantly used in nonviral gene therapy clinical ...